Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of residual intramuscular myxoma

Anand Zade; Archana Ahire; Shishir Shetty; Sujith Rai; Rajashekharrao Bokka; Arokiaswamy Velumani; Rasika Kabnurkar

doi:10.4103/0972-3919.147553

Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of residual intramuscular myxoma

Indian J Nucl Med. 2015 Jan-Mar;30(1):75-7. doi: 10.4103/0972-3919.147553.

Authors

Anand Zade¹, Archana Ahire², Shishir Shetty³, Sujith Rai¹, Rajashekharrao Bokka¹, Arokiaswamy Velumani¹, Rasika Kabnurkar⁴

Affiliations

¹ Department of Molecular Imaging, Nueclear Healthcare Ltd., Kopar Khairane, Navi Mumbai, India.
² Department of Radiology, Jupiter Hospital, Thane, India.
³ Department of Oncology, Fortis Hiranandani Hospital, Vashi, Navi Mumbai, India.
⁴ Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.

Abstract

Intramuscular myxoma (IM) is a rare benign neoplasm. In a patient diagnosed with IM of left thigh, we report the utility of a postoperative fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography scan in assessing the efficacy of surgical excision.

Keywords: Fluorine-18 fluorodeoxyglucose; intramuscular myxoma; positron emission tomography-computed tomography scan.

Publication types

Case Reports